Avaxmed Limited

Active10908112 Private limited company
Incorporated
9 August 2017 (9 years)
Previously known as
Avaxzipen Limited (until 8 September 2025)
Enesi Pharma Limited (until 4 January 2023)
Industry
Other research and experimental development on natural sciences and engineering (72190)
Directors
Robin David Cohen
Owned by
Anthony Taylor Rowlands
Accounts type
Full
Region
South East
Address
120A&B Olympic Avenue
Milton Park
Abingdon
OX14 4SA

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt due
21 August 2027
Last conf. stmt
7 August 2026

Charges

Total
4
Outstanding
1
Part satisfied
0
Satisfied
3

Officers 1 active

Officer details are public data from the Companies House register.

Cohen, Robin David
Director · Appointed 16 February 2023
British
Born November 1972
Officer history (8 former)
22 September 2026
Resigned Stoddart, Karen Lesley as Director
2 March 2026
Resigned Mercer, Carolyn Victoria, Dr as Director
17 April 2025
Resigned Lloyd, Carol May as Secretary
24 September 2024
Appointed Mercer, Carolyn Victoria, Dr as Director
1 March 2024
Appointed Stoddart, Karen Lesley as Director
31 March 2023
Resigned Eagling-Vose, Elizabeth Sarah as Director
16 February 2023
Appointed Cohen, Robin David as Director
25 July 2022
Resigned Hipkiss, David John as Director
1 April 2022
Appointed Eagling-Vose, Elizabeth Sarah as Director
15 December 2021
Resigned Bush, Andrew James as Director
27 September 2021
Appointed Lloyd, Carol May as Secretary
31 March 2021
Resigned Bonnet, Ludovic Gregoire, Dr as Director
12 November 2018
Appointed Bonnet, Ludovic Gregoire, Dr as Director
11 April 2018
Resigned Schmidt, Meinhard Folkert as Director
6 September 2017
Appointed Hipkiss, David John as Director
6 September 2017
Appointed Schmidt, Meinhard Folkert as Director
9 August 2017
Appointed Bush, Andrew James as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Anthony Taylor Rowlands
Individual · Notified 9 August 2017
Owns 75–100% of shares
Holds 75–100% of voting rights
British
Born June 1956 (70)

Financials

Balance sheet as at 31 December 2025 · full accounts

Cash
£301,134
Turnover
£363,743
Profit
(£5,855,486)

Trend

Cash
£0 £500k £1.0M £1.5M 2019 2020 2021 2022 2023 2025 £1,023,812 £295,001 £487,974 £469,932 £265,535 £301,134
Balance sheet detail
202520232022202120202019
Current Assets£1,190,385£1,279,369£1,749,737£2,138,396£1,398,085£2,161,228
Cash£301,134£265,535£469,932£487,974£295,001£1,023,812

Turnover£363,743
Staff Costs£2,105,131£2,009,266£2,097,992£1,981,847£1,661,777£1,407,473
Profit for Period(£5,855,486)(£4,353,321)(£4,943,760)(£3,636,935)(£3,465,271)(£3,567,263)

Filings 73

DateDescriptionMade Up ToPagesPDF
5 October 2026Termination of appointment of a director
20 August 2026Confirmation statement with updates7 August 2026
27 March 2026Full accounts31 December 2025
2 March 2026Termination of appointment of a director
17 September 2025Memorandum and Articles of Association
Show all 73 filings

Other companies in this industry

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?